Abstract:Background: Artificial intelligence (AI) has the capability to analyze vast amounts of data and has been applied in various healthcare sectors. However, its effectiveness in aiding pharmacotherapy decision-making remains uncertain due to the intricate, patient-specific, and dynamic nature of this field. Objective: This study sought to investigate the potential of AI in guiding pharmacotherapy decisions using clinical data such as diagnoses, laboratory results, and vital signs obtained from routine patient care. Methods: Data of a previous study on medication therapy optimization was updated and adapted for the purpose of this study. Analysis was conducted using R software along with the tidymodels extension packages. The dataset was split into 74% for training and 26% for testing. Decision trees were selected as the primary model due to their simplicity, transparency, and interpretability. To prevent overfitting, bootstrapping techniques were employed, and hyperparameters were fine-tuned. Performance metrics such as areas under the curve and accuracies were computed. Results: The study cohort comprised 101 elderly patients with multiple diagnoses and complex medication regimens. The AI model demonstrated prediction accuracies ranging from 38% to 100% for various cardiovascular drug classes. Laboratory data and vital signs could not be interpreted, as the effect and dependence were unclear for the model. The study revealed that the issue of AI lag time in responding to sudden changes could be addressed by manually adjusting decision trees, a task not feasible with neural networks. Conclusion: In conclusion, the AI model exhibited promise in recommending appropriate medications for individual patients. While the study identified several obstacles during model development, most were successfully resolved. Future AI studies need to include the drug effect, not only the drug, if laboratory data is part of the decision. This could assist with interpreting their potential relationship. Human oversight and intervention remain essential for an AI-driven pharmacotherapy decision support system to ensure safe and effective patient care.

Application of Drug Allocation Treatment Based on Decision Tree Algorithm

Analysis of Coronary Heart Disease Drug Therapy Based on Clinical Data Mining

Study on the Application of Classification Tree Model in Screening the Risk Factors of Malignant Tumor

Application of a Decision Tree Model for Predicting Diabetic Retinopathy

Evaluating the Effectiveness of Index-Based Treatment Allocation

Drug Safety Signal Detection in a Regional Healthcare Database Using the Tree-Based Scan Statistic and Comparison to 3 Other Mining Methods

Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees

The application of a decision tree to establish the parameters associated with hypertension

Non-greedy Tree-based Learning for Estimating Global Optimal Dynamic Treatment Decision Rules with Continuous Treatment Dosage

An Economic Decision-Making Model for Drugs Using Big Data and Convolution Neural Network in Healthcare

Application of random forest based on semi-automatic parameter adjustment for optimization of anti-breast cancer drugs

Assessment of the Risk Factors in the Daily Life of Stroke Patients Based on an Optimized Decision Tree

A drug mix and dose decision algorithm for individualized type 2 diabetes management

Adaptively leverage multiple real-world data sources for treatment effect estimation based on similarity

Classification And Prediction Of Chronic Kidney Disease Using Novel Decision Tree Algorithm By Comparing Random Forest For Obtaining Better Accuracy

Treatment Allocation under Uncertain Costs

An efficient approach for optimizing the cost-effective individualized treatment rule using conditional random forest

A Decision Tree Based Method for Treatment Therapy of HCC

Artificial intelligence to assist decision-making on pharmacotherapy: A feasibility study

1. Applications of Genetic Algorithms to the Prediction of Blood-Brain Partitioning of a Large Set of Drugs

A Novel Drug Selection Decision Support Model Based on Real-World Medical Data by the Hybrid Entropic Weight TOPSIS Method